HCAP Partners and Baymark Partners Invest in DFW Neuropathy

September 27, 2022

Baymark Partners led an investment in DFW Neuropathy, a North Texas neuropathy treatment clinic, with HCAP Partners joining as an investor. The capital will support DFW Neuropathy’s expansion of its Combination Electroanalgesia Treatment (CET) services across the Dallas–Fort Worth metroplex.

Buyers
Baymark Partners, HCAP Partners
Targets
DFW Neuropathy
Location
Texas, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.